47 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
-APPROVAL POLICIES AND PROCEDURES
AUDIT COMMITTEE REPORT
EXECUTIVE OFFICERS
EXECUTIVE COMPENSATION
2023 SUMMARY COMPENSATION TABLE
PLEDGING AND HEDGING … to participate in that plan on the same terms as our other employees generally.
PLEDGING AND HEDGING POLICIES
Under the terms of our Insider Trading Policy, our
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
, principal investment, hedging, financing and brokerage activities. Some of the underwriters and certain of their affiliates may in the future engage
424B5
LRMR
Larimar Therapeutics Inc
13 Feb 24
Prospectus supplement for primary offering
4:46pm
, hedging, financing and brokerage activities. Some of the underwriters and certain of their affiliates may in the future engage in investment banking
424B5
nahlx5
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-10.2
ea1sug522opo7c xrhln
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.3
rwl3ldg7 k1awqv
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
o5odm kl4
6 Aug 20
Departure of Directors or Certain Officers
9:00am
S-8
EX-4.5
xk65sba
26 Jun 20
Registration of securities for employees
5:28pm
8-K
EX-10.2
3bqeb
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
jzkvt sac7
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am